Healthcare -
Biotechnology - NASDAQ - US
$ 5.89
0.684 %
$ 252 M
Market Cap
-10.52
P/E
DMAC - TOTAL EQUITY
Total Equity DMAC - DiaMedica Therapeutics Inc.
51.1 M
LAST VALUE
7.69%
2 YEAR CAGR
24.56%
5 YEAR CAGR
43.47%
10 YEAR CAGR